Masaru Matsuoka

InstitutionSaitama Medical University Hospital
AddressSaitama
Japan
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 8 Covid-19 publications, with a maximum of 2 publications in March 2021 and April 2021 and August 2021
    All Publications
    Bar chart showing 15 publications over 7 distinct years, with a maximum of 6 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Imai K, Matsuoka M, Tabata S, Kitagawa Y, Nagura-Ikeda M, Kubota K, Fukada A, Takada T, Sato M, Noguchi S, Takeuchi S, Arakawa N, Miyoshi K, Saito Y, Maeda T. Cross-reactive humoral immune responses against seasonal human coronaviruses in COVID-19 patients with different disease severities. Int J Infect Dis. 2021 Oct; 111:68-75. PMID: 34407480.
      Citations: 1     Fields:    Translation:Humans
    2. Matsuzaki N, Orihara Y, Kodana M, Kitagawa Y, Matsuoka M, Kawamura R, Takeuchi S, Imai K, Tarumoto N, Maesaki S, Maeda T. Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS® SARS-CoV-2 Antigen Test. J Med Virol. 2021 Dec; 93(12):6778-6781. PMID: 34170555.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    3. Kodana M, Kitagawa Y, Takahashi R, Matsuoka M, Fushimi N, Sakai J, Ishibashi N, Imai K, Takeuchi S, Tarumoto N, Maesaki S, Ikezono T, Maeda T. Concerns about the clinical usefulness of saliva specimens for the diagnosis of COVID-19. J Infect. 2021 07; 83(1):119-145. PMID: 33872667.
      Citations:    Fields:    Translation:Humans
    4. Nagura-Ikeda M, Imai K, Kubota K, Noguchi S, Kitagawa Y, Matsuoka M, Tabata S, Miyoshi K, Ito T, Tamura K, Maeda T. Clinical characteristics and antibody response to SARS-CoV-2 spike 1 protein using VITROS Anti-SARS-CoV-2 antibody tests in COVID-19 patients in Japan. J Med Microbiol. 2021 Apr; 70(4). PMID: 33861191.
      Citations:    Fields:    Translation:Humans
    5. Kubota K, Kitagawa Y, Matsuoka M, Imai K, Orihara Y, Kawamura R, Sakai J, Ishibashi N, Tarumoto N, Takeuchi S, Maesaki S, Maeda T. Clinical evaluation of the antibody response in patients with COVID-19 using automated high-throughput immunoassays. Diagn Microbiol Infect Dis. 2021 Jul; 100(3):115370. PMID: 33744623.
      Citations: 1     Fields:    Translation:Humans
    6. Imai K, Kitagawa Y, Tabata S, Kubota K, Nagura-Ikeda M, Matsuoka M, Miyoshi K, Sakai J, Ishibashi N, Tarumoto N, Takeuchi S, Ito T, Maesaki S, Tamura K, Maeda T. Antibody response patterns in COVID-19 patients with different levels of disease severity in Japan. J Med Virol. 2021 May; 93(5):3211-3218. PMID: 33620098.
      Citations: 4     Fields:    Translation:Humans
    7. Fukada A, Kitagawa Y, Matsuoka M, Sakai J, Imai K, Tarumoto N, Orihara Y, Kawamura R, Takeuchi S, Maesaki S, Maeda T. Presepsin as a predictive biomarker of severity in COVID-19: A case series. J Med Virol. 2021 Jan; 93(1):99-101. PMID: 32530491.
      Citations: 10     Fields:    Translation:Humans
    8. Kitagawa Y, Orihara Y, Kawamura R, Imai K, Sakai J, Tarumoto N, Matsuoka M, Takeuchi S, Maesaki S, Maeda T. Evaluation of rapid diagnosis of novel coronavirus disease (COVID-19) using loop-mediated isothermal amplification. J Clin Virol. 2020 08; 129:104446. PMID: 32512376.
      Citations: 35     Fields:    Translation:HumansCellsPHPublic Health